Free Trial

Remedium Capital Partners, LLC Top Holdings and 13F Report (2026)

About Remedium Capital Partners, LLC

Investment Activity

  • Remedium Capital Partners, LLC has $319.77 million in total holdings as of March 31, 2026.
  • Remedium Capital Partners, LLC owns shares of 6 different stocks, but just 4 companies or ETFs make up 80% of its holdings.
  • Approximately 27.87% of the portfolio was purchased this quarter.
  • This quarter, Remedium Capital Partners, LLC has purchased 6 new stocks and bought additional shares in 3 stocks.
  • Remedium Capital Partners, LLC sold shares of 0 stocks and completely divested from 0 stocks this quarter.

Largest Holdings

Spyre Therapeutics Inc
$96,205,574
Oruka Therapeutics Inc
$92,661,091
Damora Therapeutics Inc
$52,977,750
Apogee Therapeutics Inc
$49,120,854
Jade Biosciences Inc
$22,167,388

Largest Purchases this Quarter

Damora Therapeutics Inc
1,925,000 shares (about $49.86M)
Spyre Therapeutics Inc
451,096 shares (about $22.75M)
Oruka Therapeutics Inc
336,701 shares (about $16.52M)

Sector Allocation Over Time

Map of 500 Largest Holdings ofRemedium Capital Partners, LLC

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
Spyre Therapeutics Inc
$96,205,574$22,753,282 â–²31.0%1,907,32730.1%COM
Oruka Therapeutics Inc
$92,661,091$16,515,184 â–²21.7%1,889,11529.0%COM
Damora Therapeutics Inc
$52,977,750$49,857,499 â–²1,597.9%2,045,47316.6%COM
Apogee Therapeutics Inc
$49,120,8540.0%583,59115.4%COM
Jade Biosciences Inc
$22,167,3880.0%1,577,7506.9%COM
Crescent Biopharma Inc
$6,636,1630.0%361,2502.1%COM

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data